Article Details

Subcutaneous Versus IV Nivolumab for Kidney Cancer - NCI

Retrieved on: 2024-03-13 17:37:34

Tags for this article:

Click the tags to see associated articles and topics

Subcutaneous Versus IV Nivolumab for Kidney Cancer - NCI. View article details on hiswai:

Excerpt

The immune system can generate antibodies against medicines, especially those like nivolumab that are made from human or animal proteins. Although ...

Article found on: www.cancer.gov

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo